Preventive stRategy for IMMU132-relatED AEs in TNBC
Conditions: Triple Negative Breast Cancer; Breast Cancer Interventions: Drug: Sacituzumab govitecan; Drug: Loperamide; Drug: Granulocyte Colony-Stimulating Factor Sponsors: MedSIR; Gilead Sciences Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials